
Welkom bij Campus Sanofi Nederland
- Artikel
- Campus Sanofi
- 19 mrt 2024
Een platform voor beroepsbeoefenaren om betrouwbare en relevante informatie over onze medicijnen en therapieën te vinden.
InloggenDeze website is uitsluitend voorbehouden aan beroepsbeoefenaren in Nederland.


The Type 1 Diabetes (T1D) field is evolving. Recognition of the presymptomatic stages in T1D is growing.1-4 The clinical benefits of early detection of T1D are being highlighted.3-4 Programmes focusing on early detection through testing and screening for presymptomatic autoimmune T1D are increasingly offered to risk populations and the general population.1,2

Autoimmune Type 1 diabetes (T1D) is undergoing a fundamental transformation in how the medical community approaches diagnosis and care.
